A medical dressing for scar repair and preparation method thereof

By modifying the combination of carboxymethyl chitosan and other ingredients, a medical dressing for scar repair was prepared, which solved the problems of unstable ingredients of existing dressings and long healing time, achieving rapid healing and good scar repair Effect.

CN118615479BActive Publication Date: 2024-12-03ZHEJIANG TOP-MEDICAL MEDICAL DRESSING CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411116867.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-12-03
Estimated Expiration
2044-08-15

AI Technical Summary

Technical Problem

The ingredients of existing wound dressings are unstable, resulting in uneven precipitation of drug ingredients, affecting the scar repair effect, and it is difficult to effectively shorten the wound healing time.

Method used

The preparation and specificity of modified carboxymethyl chitosan using a medical dressing formula consisting of polyvinyl alcohol, modified carboxymethyl chitosan, BPC157, allopurinol, dipotassium glycyrrhizate and 1,3-propylene glycol. By proportioning and processing method, a dressing with excellent antibacterial and promoting tissue regeneration effects are formed.

Benefits of technology

Significantly shortens the wound healing time, improves the internal environment, reduces scar formation, improves the film-forming, ductile and permeability of the dressing, enhances the moisture content of the skin's stratum corneum, and effectively repairs scars after wound healing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118615479B_ABST
    Figure CN118615479B_ABST
Patent Text Reader

Abstract

The present invention belongs to the technical field of medical materials, and specifically relates to a medical dressing for scar repair and a preparation method thereof. The medical dressing is composed of the following raw materials in percentage by mass: polyvinyl alcohol 7-12%, modified carboxymethyl chitosan 2-6%, BPC157 0.5-1.5%, allopurinol 1-3%, dipotassium glycyrrhizinate 0.1-0.5%, 1,3-propylene glycol 0.5-1%, and the balance is deionized water. The modified carboxymethyl chitosan in the formula has excellent antibacterial effect, can promote tissue regeneration, improve the internal environment, and thus effectively shorten the time of wound healing. Allopurinol and BPC157 synergistically form a protective layer on the wound, reduce the evaporation of water on the surface of the scar, and increase the water content of the stratum corneum of the skin, so that the scar after the wound healing can be better repaired.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of medical materials, and particularly relates to a medical dressing for scar repair and a preparation method thereof. Background Art

[0002] The skin is the largest organ in the human body and the first barrier against external damage or invasion of pathogenic microorganisms. It has the functions of protection, excretion, regulating body temperature and sensing external stimuli. It also plays a pivotal role in maintaining the dynamic balance in the human body and protecting internal organs from the influence of the external environment. In daily life, we are always exposed to various mechanical and chemical stimuli or microbial invasions, so rapid repair of skin damage is crucial to maintaining homeostasis.

[0003] As we all know, the final result of wound repair is usually closely related to the wound size, tissue and organ type, development stage and biological species. Shallow skin injuries can usually restore their barrier function, but most injuries such as burns and infected wounds usually penetrate deep into the dermis. These wounds often form scars with pigment deposition after healing. Scars not only affect the appearance, but may also cause the loss of function of organs such as the skin, affecting the patient's quality of life.

[0004] There are many kinds of dressings for wound repair at present, but there are the following problems: due to unreasonable ingredients in the formula, the drug ingredients are unstable, easy to precipitate, and unevenly distributed in the dressing, which affects the function of the dressing; the functional ingredients of the dressing are unstable, which is not conducive to wound repair and scar formation. Based on this, it is necessary to improve the ingredients of existing wound dressings. Summary of the invention

[0005] The first purpose of the present invention is to provide a medical dressing for scar repair, which can effectively shorten the wound healing time and has a good repairing effect on the scar after the wound is healed.

[0006] The second purpose of the present invention is to provide a method for preparing a medical dressing for scar repair, which has simple steps and is easy to operate.

[0007] In order to achieve the above object, the technical solution adopted by the present invention is:

[0008] A medical dressing for scar repair, comprising the following raw materials in percentage by weight: 7-12% polyvinyl alcohol, 2-6% modified carboxymethyl chitosan, 0.5-1.5% BPC157, 1-3% allopurinol, 0.1-0.5% dipotassium glycyrrhizinate, 0.5-1% 1,3-propylene glycol, and the balance being deionized water;

[0009] The preparation process of the modified carboxymethyl chitosan is as follows:

[0010] Carboxymethyl chitosan, nano-hydroxyapatite and maleic acid are added to an ethanol aqueous solution for reflux reaction. After the reaction is completed, the reaction solution is purified to obtain modified carboxymethyl chitosan.

[0011] Preferably, the mass ratio of the carboxymethyl chitosan, nano-hydroxyapatite and maleic acid is 1:0.2-0.5:1-3.

[0012] Preferably, the mass concentration of ethanol in the ethanol aqueous solution is 40-60wt%.

[0013] Preferably, the reflux reaction time is 3-4 h.

[0014] The preparation method of the above-mentioned medical dressing for scar repair comprises the following steps:

[0015] (1) Add modified carboxymethyl chitosan, 1,3-propylene glycol and polyvinyl alcohol to deionized water accounting for half of the total amount, stir evenly to obtain liquid A;

[0016] (2) Take the remaining deionized water, add BPC157, allopurinol, and dipotassium glycyrrhizinate, and disperse evenly by ultrasonication to obtain solution B;

[0017] (3) Mix the liquid A in step (1) and the liquid B in step (2) and stir them evenly, then sterilize them to obtain the product.

[0018] Preferably, the stirring speed in step (1) is 30-50 rpm and the time is 15-25 min.

[0019] Preferably, the ultrasonic dispersion in step (2) is carried out at a temperature of 50-60°C and for a time of 10-15 minutes.

[0020] Preferably, the stirring speed in step (3) is 100-120 rpm and the time is 20-30 min.

[0021] Preferably, the sterilization in step (3) is gamma ray irradiation sterilization or electron beam irradiation sterilization.

[0022] Compared with the prior art, the beneficial effects of the present invention are mainly:

[0023] The present invention provides a novel medical dressing formula for scar repair, which contains modified carboxymethyl chitosan, BPC157, allopurinol and other ingredients. The modified carboxymethyl chitosan in the formula is obtained by chemical modification using carboxymethyl chitosan, nano-hydroxyapatite and maleic acid as raw materials. The modified carboxymethyl chitosan has excellent antibacterial effect, can promote tissue regeneration, improve the internal environment, and thus effectively shorten the time of wound healing; BPC157 and allopurinol in the formula synergistically form a protective layer on the wound, reduce the evaporation of water on the scar surface, and increase the water content of the skin stratum corneum, so that the scar after wound healing can be better repaired.

[0024] In addition, the medical dressing for scar repair of the present invention also has good film-forming property, ductility and permeability. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 It is an analysis chart of the scar hyperplasia index results after using the medical dressings of Examples 1-3 and Comparative Examples 1-6. DETAILED DESCRIPTION

[0026] The technical scheme of the present invention is further described below in conjunction with specific embodiments. However, it should be understood by those skilled in the art that the following examples are only used to illustrate the present invention and should not be regarded as limiting the present invention. The specific conditions not specified in the examples are carried out according to conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used, unless otherwise specified, are conventional products obtained through commercial channels.

[0027] 1. Preparation Example

[0028] Preparation Example 1

[0029] This preparation example provides a modified carboxymethyl chitosan, and the detailed preparation process is as follows:

[0030] Carboxymethyl chitosan, nano-hydroxyapatite and maleic acid were added to a 50wt% ethanol aqueous solution in a mass ratio of 1:0.4:2 and refluxed for 3.5h. After the reaction was completed, the reaction solution was centrifuged to remove water and ethanol, and the solid phase was collected, washed with water and dried to obtain modified carboxymethyl chitosan.

[0031] Preparation Example 2

[0032] This preparation example provides a modified carboxymethyl chitosan, and the detailed preparation process is as follows:

[0033] Carboxymethyl chitosan, nano-hydroxyapatite and maleic acid were added to a 40wt% ethanol aqueous solution in a mass ratio of 1:0.5:3 and refluxed for 4 hours. After the reaction was completed, the reaction solution was centrifuged to remove water and ethanol, and the solid phase was collected, washed with water and dried to obtain modified carboxymethyl chitosan.

[0034] Preparation Example 3

[0035] This preparation example provides a modified carboxymethyl chitosan, and the detailed preparation process is as follows:

[0036] Carboxymethyl chitosan, nano-hydroxyapatite and maleic acid were added to a 60wt% ethanol aqueous solution in a mass ratio of 1:0.2:1 and refluxed for 3 hours. After the reaction was completed, the reaction solution was centrifuged to remove water and ethanol, and the solid phase was collected, washed with water and dried to obtain modified carboxymethyl chitosan.

[0037] 2. Example

[0038] Example 1

[0039] The present embodiment provides a medical dressing for scar repair, which is composed of the following raw materials in percentage by weight: 10% polyvinyl alcohol, 5% modified carboxymethyl chitosan obtained in Preparation Example 1, 1% BPC157, 2% allopurinol, 0.3% dipotassium glycyrrhizinate, 0.6% 1,3-propylene glycol, and the balance is deionized water.

[0040] This embodiment also provides a method for preparing the above-mentioned medical dressing for scar repair, and the detailed preparation process is as follows:

[0041] (1) Add modified carboxymethyl chitosan, 1,3-propylene glycol and polyvinyl alcohol to deionized water accounting for half of the total amount, and stir at 35 rpm for 20 min to obtain liquid A;

[0042] (2) Take the remaining deionized water, add BPC157, allopurinol, and dipotassium glycyrrhizinate, and disperse them by ultrasonic at 55°C for 12 min to obtain solution B;

[0043] (3) Mix solution A from step (1) and solution B from step (2), stir at 110 rpm for 25 min, and sterilize by γ-ray irradiation.

[0044] Example 2

[0045] The present embodiment provides a medical dressing for scar repair, which is composed of the following raw materials in percentage by weight: 7% polyvinyl alcohol, 6% modified carboxymethyl chitosan obtained in Preparation Example 2, 0.5% BPC157, 3% allopurinol, 0.1% dipotassium glycyrrhizinate, 0.5% 1,3-propylene glycol, and the balance is deionized water.

[0046] This embodiment also provides a method for preparing the above-mentioned medical dressing for scar repair, and the detailed preparation process is as follows:

[0047] (1) Add modified carboxymethyl chitosan, 1,3-propylene glycol and polyvinyl alcohol to deionized water accounting for half of the total amount, and stir at 30 rpm for 15 min to obtain liquid A;

[0048] (2) Take the remaining deionized water, add BPC157, allopurinol, and dipotassium glycyrrhizinate, and disperse them by ultrasonic at 60°C for 10 min to obtain solution B;

[0049] (3) Mix the solution A from step (1) and the solution B from step (2), stir at 100 rpm for 30 min, and sterilize by γ-ray irradiation.

[0050] Example 3

[0051] The present embodiment provides a medical dressing for scar repair, which is composed of the following raw materials in percentage by weight: 12% polyvinyl alcohol, 2% modified carboxymethyl chitosan obtained in Preparation Example 3, 1.5% BPC157, 1% allopurinol, 0.5% dipotassium glycyrrhizinate, 1% 1,3-propylene glycol, and the balance is deionized water.

[0052] This embodiment also provides a method for preparing the above-mentioned medical dressing for scar repair, and the detailed preparation process is as follows:

[0053] (1) Add modified carboxymethyl chitosan, 1,3-propylene glycol and polyvinyl alcohol to deionized water accounting for half of the total amount, and stir at a speed of 50 rpm for 25 min to obtain liquid A;

[0054] (2) Take the remaining deionized water, add BPC157, allopurinol, and dipotassium glycyrrhizinate, and disperse them by ultrasonic at 50°C for 15 min to obtain solution B;

[0055] (3) Mix the solution A from step (1) and the solution B from step (2), stir at 120 rpm for 20 min, and sterilize by electron beam irradiation.

[0056] 3. Comparative ratio

[0057] Comparative Example 1

[0058] This comparative example provides a medical dressing, which is composed of the following raw materials in percentage by weight: 10% polyvinyl alcohol, 5% carboxymethyl chitosan, 1% BPC157, 2% allopurinol, 0.3% dipotassium glycyrrhizinate, 0.6% 1,3-propylene glycol, and the balance is deionized water, and the rest is the same as in Example 1.

[0059] Comparative Example 2

[0060] This comparative example provides a medical dressing, which is composed of the following raw materials in percentage by weight: 10% polyvinyl alcohol, 3.6% carboxymethyl chitosan, 1.4% nano-hydroxyapatite, 1% BPC157, 2% allopurinol, 0.3% dipotassium glycyrrhizinate, 0.6% 1,3-propylene glycol, and the balance is deionized water, and the rest is the same as in Example 1.

[0061] Comparative Example 3

[0062] This comparative example provides a medical dressing, which is composed of the following raw materials in percentage by weight: 10% polyvinyl alcohol, 5% modified carboxymethyl chitosan obtained in Preparation Example 1, 2% allopurinol, 0.3% dipotassium glycyrrhizinate, 0.6% 1,3-propylene glycol, and the balance is deionized water, and the rest is the same as in Example 1.

[0063] Comparative Example 4

[0064] This comparative example provides a medical dressing, which is composed of the following raw materials in percentage by weight: 10% polyvinyl alcohol, 5% modified carboxymethyl chitosan obtained in Preparation Example 1, 1% BPC157, 0.3% dipotassium glycyrrhizinate, 0.6% 1,3-propylene glycol, and the balance is deionized water, and the rest is the same as in Example 1.

[0065] Comparative Example 5

[0066] This comparative example provides a medical dressing, which is composed of the following raw materials in percentage by weight: 10% polyvinyl alcohol, 5% modified carboxymethyl chitosan obtained in Preparation Example 1, 3% allopurinol, 0.3% dipotassium glycyrrhizinate, 0.6% 1,3-propylene glycol, and the balance is deionized water, and the rest is the same as in Example 1.

[0067] Comparative Example 6

[0068] This comparative example provides a medical dressing, which is composed of the following raw materials in percentage by weight: 10% polyvinyl alcohol, 5% modified carboxymethyl chitosan obtained in Preparation Example 1, 3% BPC157, 0.3% dipotassium glycyrrhizinate, 0.6% 1,3-propylene glycol, and the balance is deionized water, and the rest is the same as in Example 1.

[0069] 4. Test examples

[0070] Test Example 1

[0071] This test example explores the physical properties of the medical dressings of Examples 1-3 and Comparative Examples 1-6. The test process is as follows:

[0072] ① Film-forming time: At room temperature, the medical dressings of Examples 1-3 and Comparative Examples 1-6 were used to form colorless, transparent, and continuous latex films. The film-forming time was calculated. The results are shown in Table 1.

[0073] ② Ductility: Take 0.05 mL of the medical dressing of Examples 1-3 and Comparative Examples 1-6 and place it at the 0 scale of the pad, drag it with a coating rod, and observe the length of the drag mark. Evaluation criteria: When the drag mark length is 3-7 cm, the ductility is qualified; when the drag mark length is 8-12 cm, the ductility is excellent. The results are shown in Table 1.

[0074] ③ Permeability: Take 0.05 mL of the medical dressing of Examples 1-3 and Comparative Examples 1-6 and cover it on a 10-layer cotton sheet with a total thickness of 10 mm, and observe its penetration. Evaluation criteria: if it penetrates 1-3 layers, the permeability is qualified; if it penetrates 4-7 layers, the permeability is good; if it penetrates more than 7 layers, the permeability is excellent. The results are shown in Table 1.

[0075] Table 1

[0076] Grouping Film forming time (s) Drag trace length (cm) Number of penetration layers Example 1 3.8 10.5 10 Example 2 4.0 10.2 10 Example 3 4.3 9.9 9 Comparative Example 1 5.2 9.0 8 Comparative Example 2 5.4 8.5 8 Comparative Example 3 8.6 5.9 7 Comparative Example 4 6.3 7.4 6 Comparative Example 5 8.5 6.2 8 Comparative Example 6 5.6 8.0 5

[0077] It can be seen from Table 1 that the medical dressings of Examples 1-3 have better film-forming properties, extensibility and permeability than those of Comparative Examples 1-6.

[0078] Test Example 2

[0079] This test example explores the antibacterial properties of the medical dressings of Examples 1-3 and Comparative Examples 1-6. The test process is as follows:

[0080] The activated Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa were inoculated on a common broth agar plate and cultured at 37°C for 24 h. The cells were appropriately diluted with nutrient broth (10 8 CFU / mL), then add the medical dressings prepared in Examples 1-3 and Comparative Examples 1-6, incubate at room temperature for 1 hour, take 50 μL of each and apply it on a plate, invert and culture at 37°C for 24 hours, observe the growth of colonies and count the number of colonies. The present invention also sets sterile water as a blank control group, and each group sets 3 parallel tests. The inhibition rate = (the total number of colonies in the blank control group - the total number of colonies in the test group) / the total number of colonies in the blank control group × 100%. The results are shown in Table 2.

[0081] Table 2

[0082] Grouping / inhibition rate (%) Staphylococcus aureus Pseudomonas aeruginosa Escherichia coli Example 1 97.7 86.5 93.4 Example 2 97.1 85.8 92.9 Example 3 96.8 85.3 92.1 Comparative Example 1 84.0 74.2 83.6 Comparative Example 2 88.1 77.9 86.4 Comparative Example 3 93.8 82.0 89.7 Comparative Example 4 96.4 85.1 92.0 Comparative Example 5 94.6 82.7 90.1 Comparative Example 6 95.2 83.8 91.5

[0083] It can be seen from Table 2 that the antibacterial properties of the medical dressings of Comparative Examples 1-2 are significantly lower than those of Examples 1-3, and the antibacterial properties of the medical dressings of Comparative Example 2 are higher than those of the medical dressings of Comparative Example 1. As can be seen from the above, the use of carboxymethyl chitosan instead of modified carboxymethyl chitosan in the medical dressing formula of Comparative Example 1, and the use of carboxymethyl chitosan and nano-hydroxyapatite instead of modified carboxymethyl chitosan in the medical dressing formula of Comparative Example 2 will both lead to a decrease in the antibacterial properties of the medical dressings, and the decrease trend of the medical dressing of Comparative Example 1 is more obvious. In summary, compared with carboxymethyl chitosan, carboxymethyl chitosan and nano-hydroxyapatite, the modified carboxymethyl chitosan prepared by the present invention has a better antibacterial effect.

[0084] Compared with Examples 1-3, the antibacterial properties of the medical dressings of Comparative Examples 3 and 5 are reduced, and there is no significant difference in the antibacterial properties of the medical dressings of Comparative Examples 3 and 5. BPC157 is omitted from the formula of the medical dressing of Comparative Example 3, and BPC157 is omitted from the formula of the medical dressing of Comparative Example 5, and the amount of allopurinol used is increased. As can be seen from the above, changing the amount of BPC157 used in the formula will affect the antibacterial properties of the medical dressing.

[0085] Compared with Examples 1-3, the antibacterial performance of the medical dressing of Comparative Example 4 is not significantly different. From the above, it can be seen that although allopurinol is omitted from the formula of the medical dressing of Comparative Example 4, it does not affect the antibacterial performance of the medical dressing.

[0086] Compared with Examples 1-3, the antibacterial performance of the medical dressing of Comparative Example 6 is slightly reduced. As can be seen from the above, the medical dressing formula of Comparative Example 6 omits allopurinol and increases the amount of BPC157 used, which reduces the antibacterial performance of the medical dressing.

[0087] Test Example 3

[0088] This test example explores the wound repair performance of the medical dressings of Examples 1-3 and Comparative Examples 1-6. The test process is as follows:

[0089] Test subjects: 90 male rats, weighing 240-250 g, were randomly divided into 9 groups.

[0090] Experimental process: The rats in each group were anesthetized with compound ketamine, the back hair was removed and the rats were fed normally for 3 days, and a circular wound with a diameter of 1.5 cm was made with surgical scissors. The medical dressings of Examples 1-3 and Comparative Examples 1-6 were applied to each group of animals on the second day of the operation, twice a day.

[0091] (1) Routine observations of animal behavior and wound appearance were performed every day, and the wound area of ​​the animals was measured every other day. The results are shown in Table 3.

[0092] (2) Calculate the scar hyperplasia index of each group of rats. Scar hyperplasia index = vertical height from the highest point of scar protrusion to subcutaneous muscle tissue ÷ vertical height from the normal skin surface around the scar to subcutaneous muscle tissue. The results are shown in Figure 1 shown.

[0093] Table 3

[0094] Grouping 50% wound healing time (d) 100% wound healing time (d) Example 1 5.1 14.3 Example 2 5.2 14.7 Example 3 5.5 15.0 Comparative Example 1 8.3 19.1 Comparative Example 2 7.5 18.2 Comparative Example 3 6.4 16.6 Comparative Example 4 5.3 14.9 Comparative Example 5 6.2 16.4 Comparative Example 6 5.0 14.1

[0095] It can be seen from Table 3 that the 50% wound healing time and 100% wound healing time of the comparative example 1-2 group are significantly higher than those of the embodiment 1-3 group. However, the modified carboxymethyl chitosan component of the present invention is not used in the formula of the comparative example 1-2 group. It can be seen from the above that the modified carboxymethyl chitosan can promote tissue regeneration, improve the internal environment, and thus effectively shorten the wound healing time.

[0096] Compared with Examples 1-3, the 50% wound healing time and 100% wound healing time of Comparative Examples 3 and 5 were slightly increased. This is because the BPC157 component was omitted from the formula of Comparative Examples 3 and 5.

[0097] Compared with Example 1-3 groups, there was no significant difference in the 50% wound healing time and the 100% wound healing time of Comparative Example 4 group.

[0098] Compared with Example 1-3, the 50% wound healing time and 100% wound healing time of Comparative Example 6 were slightly shortened, which was due to the addition of BPC157 component in Comparative Example 6.

[0099] observe Figure 1 It can be seen that compared with the comparative examples 1-6, the embodiment 1-3 group can effectively reduce the scar hyperplasia index. Among them, the scar hyperplasia index of the comparative examples 3-6 groups is significantly higher. The comparative example 3 group omitted BPC157, the comparative example 4 group omitted allopurinol, the comparative example 5 group omitted BPC157, increased the usage of allopurinol, and the comparative example 6 group omitted allopurinol and increased the usage of BPC157. It can be seen from the above that allopurinol and BPC157 synergistically form a protective layer on the wound surface, reduce the evaporation of water on the scar surface, and increase the water content of the skin stratum corneum, so that the scar after the wound healing can be better repaired.

[0100] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit them. The basic principles and main features of the present invention have been described above with specific implementation schemes. On the basis of the present invention, some modifications or replacements may be made thereto, but these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the scope of protection claimed by the present invention.

Claims

1. A medical dressing for scar repair, characterized in that: The invention is composed of the following raw materials in percentage by weight: 7-12% polyvinyl alcohol, 2-6% modified carboxymethyl chitosan, 0.5-1.5% BPC157, 1-3% allopurinol, 0.1-0.5% dipotassium glycyrrhizinate, 0.5-1% 1,3-propylene glycol, and the balance is deionized water; The preparation process of the modified carboxymethyl chitosan is as follows: Carboxymethyl chitosan, nano-hydroxyapatite and maleic acid are added to an aqueous solution of ethanol for reflux reaction. After the reaction is completed, the reaction solution is purified to obtain modified carboxymethyl chitosan. Wherein, the mass ratio of the carboxymethyl chitosan, nano-hydroxyapatite and maleic acid is 1:0.2-0.5:1-3; The mass concentration of ethanol in the aqueous solution of ethanol is 40-60wt%; The reflux reaction time is 3-4h.

2. The method for preparing a medical dressing for scar repair according to claim 1, characterized in that: The following steps are involved: (1) Add modified carboxymethyl chitosan, 1,3-propylene glycol and polyvinyl alcohol to deionized water accounting for half of the total amount, stir evenly to obtain liquid A; (2) Take the remaining deionized water, add BPC157, allopurinol, and dipotassium glycyrrhizinate, and disperse evenly by ultrasonication to obtain solution B; (3) Mix the liquid A in step (1) and the liquid B in step (2) and stir them evenly, then sterilize them to obtain the product.

3. The method for preparing the medical dressing for scar repair according to claim 2, characterized in that: The stirring speed in step (1) is 30-50 rpm and the stirring time is 15-25 min.

4. The method for preparing the medical dressing for scar repair according to claim 2, characterized in that: The ultrasonic dispersion in step (2) is carried out at a temperature of 50-60°C and for a time of 10-15 minutes.

5. The method for preparing the medical dressing for scar repair according to claim 2, characterized in that: The stirring speed in step (3) is 100-120 rpm and the time is 20-30 min.

6. The method for preparing the medical dressing for scar repair according to claim 2, characterized in that: The sterilization in step (3) is gamma ray irradiation sterilization or electron beam irradiation sterilization.